Provided by Tiger Trade Technology Pte. Ltd.

NeoGenomics

16.98
+0.45002.72%
Pre-market: 16.72-0.2600-1.53%09:01 EDT
Volume:1.14M
Turnover:19.23M
Market Cap:2.17B
PE:-42.21
High:17.08
Open:16.60
Low:16.21
Close:16.53
52wk High:17.08
52wk Low:6.38
Shares:128.00M
Float Shares:117.00M
Volume Ratio:0.78
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4023
EPS(LYR):-0.8433
ROE:-6.33%
ROA:-1.89%
PB:2.77
PE(LYR):-20.14

Loading ...

Neogenomics Agrees to Pay USD 9.81 Million to Settle DOJ Probe Tied to Lab Collaboration Program

Reuters
·
Jul 21

Neogenomics - to Pay $9.81 Mln Plus 4.25% Interest from Jan 16, 2026 to Resolve Matter

THOMSON REUTERS
·
Jul 21

Neogenomics - Finalizes Civil Settlement with DOJ and Oig Resolving Investigation

THOMSON REUTERS
·
Jul 21

Neogenomics Announces Settlement of Voluntary Disclosure to Oig-hhs

THOMSON REUTERS
·
Jul 21

Xi'an Jiaotong University Receives Another Anonymous Donation, This Time Totaling 30 Million Yuan

Deep News
·
Jul 19

International Student Deceives Elderly Parents into Borrowing Millions, Sentenced to 11 Years for Fraud

Deep News
·
Jul 19

Neo Performance Materials Inc (NEO) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
Jul 16

Sidoti Reaffirms Their Hold Rating on Neo Performance Materials Inc (NEO)

TIPRANKS
·
Jul 14

ATB Cormark Capital Markets Reaffirms Their Buy Rating on Neo Performance Materials Inc (NEO)

TIPRANKS
·
Jul 14

Does NeoGenomics (NEO) New PTEN CDx Move Reveal a Deeper Precision Oncology Strategy Shift?

Simply Wall St.
·
Jul 14

NeoGenomics Launches First FDA-Approved Prostate Cancer Companion Diagnostic

Deep News
·
Jul 09

NeoGenomics launches FDA-approved PTEN IHC prostate Cancer ompanion diagnostic

TIPRANKS
·
Jul 09

Neogenomics Launches Fda-approved Pten Ihc Companion Diagnostic for Prostate Cancer

THOMSON REUTERS
·
Jul 09

Press Release: Neogenomics to Report Second Quarter 2026 Financial Results on July 28, 2026

Dow Jones
·
Jul 07

Neogenomics on Track for Longest Winning Streak Since February 2019

Dow Jones
·
Jul 06

ATB Cormark Capital Markets Keeps Their Buy Rating on Neo Performance Materials Inc (NEO)

TIPRANKS
·
Jun 30

Deltic Energy Agrees Sale to NEO NEXT+ as North Sea Portfolio Advances

TIPRANKS
·
Jun 26

Neogenomics Director Carolyn S. Starrett Files Initial Beneficial Ownership Statement

Reuters
·
Jun 26

Neogenomics Appoints Flatiron Health Ex-ceo Carolyn Starrett to Board

Reuters
·
Jun 25

Neogenomics Appoints Carolyn Starrett to Its Board of Directors

THOMSON REUTERS
·
Jun 25